• L.M. Zakhartseva Bogomolets National Medical University
  • H.E. Chytaieva Bogomolets National Medical University
  • O.V. Artemov Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine



immunohistochemistry, lung neuroendocrine carcinoma, morphological diagnostics, ocular metastasis


Background: Metastases in eye structures are rare (1–5% cases at systemic spread of different malignancies, mainly breast and lung cancers). The prognosis is poor. The overall survival usually does not exceed 12 or even 6 months. If metastases are found in the choroid membrane, the probability that the patient has multiple metastatic lesions of other organs increases significantly. Lung neuroendocrine neoplasms are rare (1–2% of all malignancies in adults), but mainly aggressive tumors. They are cha­racterized by “blurred”, nonspecific clinical symptoms, the correct diagnosis is delayed seriously, and distant metastases are seen in more than 40% of patients (usually in chest structures, liver, bones, brain, and adrenal glands; metastasis to vascular membrane of the eye ranks the 6th place). Case report: Own clinical observation of a male patient with rare metastasis of lung neuroendocrine carcinoma to the choroid of the left eye is presented. The disease is manifested by an ocular metastasis, which was initially considered an embryonic tumor. Other metastatic lesions (hilar lymph nodes, liver, soft tissues) were detected on computed tomography a little bit later. The diagnostic algorithm using routine histological examination and immunohistochemistry, including detection of neuroendocrine markers (chromogranin A, synaptophysin), cytokeratin 7 and Ki-67 expression in primary and metastatic tumors is described.


Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease. J Thor Oncol 2017; 12: 425–36.

Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 2018; 68: 471–87.

Oronsky B, Ma PC, Morgensztern D, et al. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia 2017; 19: 991–1002.

Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tin the United States. JAMA Oncol 2017; 3: 1335–42.

Reed CT, Duma N, Halfdanarson T, et al. Primary neuroendocrine carcinoma of the brain. BMJ Case Rep 2019; 12: e230582.

Ciobanu OA, Martin S, Fica S. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Exp Ther Med 2021; 22: 1479.

Gosain R, Mukherjee S, Yendamuri SS, et al. Management of typical and atypical pulmonary carcinoids based on different established guidelines. Cancers (Basel) 2018; 10: 510.

Hung YP. Neuroendocrine tumors of the lung: updates and diagnostic pitfalls. Surg Pathol Clin 2019; 12: 1055–71.

Prinzi N, Rossi RE, Proto C, et al. Recent advances in the management of typical and atypical lung carcinoids. Clin Lung Cancer 2021; 22: 161–9.

Metovic J, Barella M, Bianchi F, et al. Morphologic and molecular classification of lung neuroendocrine neoplasms. Virchows Arch 2021; 478: 5–19.

Ramirez RA, Chauhan A, Gimenez J, et al. Management of pulmonary neuroendocrine tumors. Rev Endocr Metab Disord 2017; 18: 433–42.

Jakubikova L. Atypical course of typical lung carcinoid. Klin Oncol 2020; 33: 302–8.

Limaiem F, Tariq MA, Wallen JM. Lung Carcinoid Tumors. In: StatPearls. Treasure Islands: StatPearls Publishing LLC, 2021. Bookshelf ID: NBK537080. PMID: 30725765

Garcia de de Jesus K, Gupta S, Hoque MR, et al. A fatal case of large cell neuroendocrine lung cancer metastatic to the brain: a case report. Cureus 2019; 11: e4728.

DeMarinis A, Malik F, Matin T, et al. A rare case of metastatic small cell neuroendocrine carcinoma of the lung presenting as isolated thrombocytopenia. J Community Hosp Intern Med Perspect 2019; 9: 327–9.

Riihimaki M, Hemminki A, Sundquist K, et al. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer 2016; 139: 2679–86.

Liu S-L, Nie Y-H, He T, et al. Iris metastasis as the first sign of small cell lung cancer: a case report. Oncol Lett 2017; 13: 1547–52.

Varghese S, Adnan MM, Khawandanah M, et al. Isolated ocular metastases from lung cancer. JSCO 2018; 16: e106-e109.

Chen H-F, Wang W-X, Li X-F, et al. Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: a case report. WJCC 2020; 8: 410–5.

Niu FY, Zhou Q, Yang JJ, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer 2016; 16: 149.

Hermans BCM, de Vos-Geelen J, Derks JL, et al. Unique metastatic patterns in neuroendocrine neoplasms of different primary origin. Neuroendocrinology 2021; 111: 1111–20.

Salah S, Khader J, Yousef Y, et al. Choroidal metastases as the sole initial presentation of metastatic lung cancer: case report and review of literature. Nepal J Ophthalmol 2012; 4: 339–42.

Lampaki S, Kioumis I, Pitsiou G, et al. Lang cancer and lung metastases. Med Hypothesis Discov Innov Ophthalmol 2014; 3: 40–4. PMID: 25738158

Muhd H, Zuhaimy H, Ismail MF, et al. Orbital metastasis as the presentation of breast cancer. Malays Family Physician 2020; 15: 74–8. PMID: 33329865

Allen RC. Orbital metastases: when to suspect? When to biopsy? Middle East Afr J Ophthalmol 2018; 25: 60–4.

Eldesouky MA, Elbakary MA. Clinical and imaging characteristics of orbital metastatic lesions among Egyptian patients. Clin Ophthalmol 2015; 9: 1683–7.

Singh N, Kulkarni P, Aggarwal AN, et al. Choroidal metastasis as a presenting manifestation of lung cancer: a repost of 3 cases and systematic review of the literature. Medicine (Baltimore) 2012; 91: 179–94.

Foo FY, Lee M, Looi A. Asymptomatic pancreatic adenocarcinoma presenting as an orbital metastatic tumor. Orbit (Amsterdam, Netherlands) 2010; 29: 262–5.

Kinslow CJ, May MS, Saqi A, et al. Large-cell neuroendocrine carcinoma of the lung: a population-based study. Clin Lung Cancer 2020; 21: e99–113.




How to Cite

Zakhartseva, L., Chytaieva, H., & Artemov, O. (2023). CLINICAL CASE OF NON-TYPICAL METASTASIS OF NEUROENDOCRINE LUNG CARCINOMA TO THE VASCULAR MEMBRANE OF THE EYE. Experimental Oncology, 44(2), 169–173.